Trials disagree over utility of PSA screening for prostate cancer - UPDATE
This article was originally published in Clinica
Executive Summary
Two trials designed to determine whether screening men for elevated levels of prostate-specific antigen (PSA) reduces the number of deaths from prostate cancer have reported contradictory results.